CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $22,000 | -29.0% | 19,308 | -8.6% | 0.00% | – |
Q2 2022 | $31,000 | -63.1% | 21,127 | -41.9% | 0.00% | – |
Q1 2022 | $84,000 | -61.6% | 36,346 | -54.3% | 0.00% | – |
Q4 2021 | $219,000 | -22.1% | 79,462 | +69.7% | 0.00% | – |
Q3 2021 | $281,000 | +242.7% | 46,816 | +179.2% | 0.00% | – |
Q2 2021 | $82,000 | -31.1% | 16,766 | -86.3% | 0.00% | – |
Q2 2019 | $119,000 | +376.0% | 122,080 | +416.3% | 0.00% | – |
Q4 2018 | $25,000 | -93.3% | 23,646 | -60.8% | 0.00% | – |
Q3 2018 | $371,000 | +1.6% | 60,256 | +76.8% | 0.00% | – |
Q2 2018 | $365,000 | -28.0% | 34,077 | -27.8% | 0.00% | – |
Q1 2018 | $507,000 | +52.7% | 47,206 | -0.4% | 0.00% | – |
Q4 2017 | $332,000 | +3.4% | 47,378 | +29.2% | 0.00% | – |
Q3 2017 | $321,000 | +0.9% | 36,671 | +5.1% | 0.00% | – |
Q2 2017 | $318,000 | -8.6% | 34,888 | -20.4% | 0.00% | – |
Q1 2017 | $348,000 | +18.4% | 43,852 | +33.4% | 0.00% | – |
Q4 2016 | $294,000 | +16.7% | 32,880 | -8.7% | 0.00% | – |
Q2 2016 | $252,000 | – | 36,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |